CJC-1295 with DAC 5mg

CJC-1295 with DAC (Drug Affinity Complex) is an extended-duration Growth Hormone-Releasing Hormone (GHRH) analogue engineered to provide continuous, sustained elevation of growth hormone (\text{GH}) and insulin-like growth factor 1 (IGF-1) levels.

The structural backbone of CJC-1295 with DAC is a 30-amino-acid modified peptide sequence covalently bonded to a bioconjugate Drug Affinity Complex moiety at its C-terminus. This DAC lysine complex enables the peptide to dynamically bind to endogenous serum albumin following administration, protecting it from rapid enzymatic cleavage and extending its biological half-life from minutes to approximately 6 to 8 days.

CJC-1295 with DAC’s primary scope of research expands into sustained endocrine, metabolic, and systemic anabolic pathways, including:

• Sustained Somatotrope Activation
• Systemic Nitrogen Retention & Protein Synthesis
• Targeted Lipolysis & Nutrient Partitioning
• Accelerated Musculoskeletal Repair
• Enhanced Systemic Recovery Profiles

THIS PRODUCT IS INTENDED FOR IN VITRO LABORATORY RESEARCH AND DEVELOPMENT USE ONLY.